{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T03:37:18Z","timestamp":1648784238757},"reference-count":19,"publisher":"Western Journal of Emergency Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.5811\/cpcem.2016.12.33002","type":"journal-article","created":{"date-parts":[[2017,5,3]],"date-time":"2017-05-03T17:35:48Z","timestamp":1493832948000},"page":"122-125","source":"Crossref","is-referenced-by-count":2,"title":["Should Pharmacies Be Included in Medication Reconciliation? A Report of Recurrent Valproic Acid Toxicity"],"prefix":"10.5811","volume":"1","author":[{"given":"B. Tate","family":"Cutshall","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samarth P.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan A.","family":"Van Berkel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanise","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. Jeff","family":"Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica V.","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3840","published-online":{"date-parts":[[2017,3,15]]},"reference":[{"issue":"6","key":"key20170503173538_b1-cpcem-01-122","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1310\/hpj5006-505","article-title":"Clinical and Financial Impact of Pharmacist Involvement in Discharge Medication Reconciliation at an Academic Medical Center: A Prospective Pilot Study","volume":"50","author":"Sebaaly","year":"2015","journal-title":"Hosp Pharm"},{"key":"key20170503173538_b2-cpcem-01-122","volume-title":"Divalproex sodium [package insert]","year":"2016"},{"key":"key20170503173538_b3-cpcem-01-122","first-page":"476","article-title":"Drugs effective in the therapy of the epilepsies","volume-title":"Goodman & Gilman\u2019s The Pharmacological basis of therapeutics","author":"McNamara","year":"1996"},{"issue":"3","key":"key20170503173538_b4-cpcem-01-122","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3109\/15563659609013799","article-title":"Delayed peak serum valproic acid in massive divalproex overdose--treatment with charcoal hemoperfusion","volume":"34","author":"Graudins","year":"1996","journal-title":"J Toxicol Clin Toxicol"},{"issue":"6","key":"key20170503173538_b5-cpcem-01-122","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2165\/00003088-198815060-00002","article-title":"Clinical pharmacokinetics of valproic acid--1988","volume":"15","author":"Zaccara","year":"1988","journal-title":"Clin Pharmacokinet"},{"issue":"7","key":"key20170503173538_b6-cpcem-01-122","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1093\/ndt\/16.7.1483","article-title":"Valproic acid overdose and haemodialysis","volume":"16","author":"Hicks","year":"2001","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"key20170503173538_b7-cpcem-01-122","doi-asserted-by":"publisher","first-page":"454","DOI":"10.3109\/15563650.2015.1035441","article-title":"Extracorporeal treatment for valproic acid poisoning: systematic review and recommendations from the EXTRIP workgroup","volume":"53","author":"Ghannoum","year":"2015","journal-title":"Clin Toxicol (Phila)"},{"key":"key20170503173538_b8-cpcem-01-122","first-page":"711","article-title":"Antidotes in depth: L-carnitine","volume-title":"Goldfrank\u2019s Toxicologic Emergencies","author":"Howland","year":"2011"},{"issue":"2","key":"key20170503173538_b9-cpcem-01-122","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"key20170503173538_b10-cpcem-01-122","first-page":"698","article-title":"Chapter: Anticonvulsants","volume-title":"Goldfrank\u2019s Toxicologic Emergencies","author":"Doyon","year":"2011"},{"key":"key20170503173538_b11-cpcem-01-122","first-page":"526469","article-title":"High-flux hemodialysis and levocarnitine in the treatment of severe valproic Acid intoxication","volume":"2013","author":"Temel","year":"2013","journal-title":"Case Rep Emerg Med"},{"issue":"1","key":"key20170503173538_b12-cpcem-01-122","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/MEJ.0b013e328345d67e","article-title":"A case of acute valproic acid poisoning treated successfully with L-carnitine","volume":"19","author":"Fontanet","year":"2012","journal-title":"Eur J Emerg Med"},{"issue":"5","key":"key20170503173538_b13-cpcem-01-122","doi-asserted-by":"publisher","first-page":"499","DOI":"10.3122\/jabfm.2007.05.070062","article-title":"Valproate-associated hyperammonemic encephalopathy","volume":"20","author":"Wadzinski","year":"2007","journal-title":"J Am Board Fam Med"},{"issue":"10","key":"key20170503173538_b14-cpcem-01-122","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1212\/WNL.56.10.1405","article-title":"Effect of L-carnitine treatment for valproate-induced hepatotoxicity","volume":"56","author":"Bohan","year":"2001","journal-title":"Neurology"},{"issue":"5","key":"key20170503173538_b15-cpcem-01-122","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/S0022-3476(82)80320-X","article-title":"Carnitine deficiency and hyperammonemia associated with valproic acid therapy","volume":"101","author":"Ohtani","year":"1982","journal-title":"J Pediatr"},{"issue":"5","key":"key20170503173538_b16-cpcem-01-122","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/j.1528-1157.1986.tb03584.x","article-title":"Serum carnitine during valproic acid therapy","volume":"27","author":"Laub","year":"1986","journal-title":"Epilepsia"},{"issue":"7","key":"key20170503173538_b17-cpcem-01-122","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1345\/aph.1M064","article-title":"Probable interaction between warfarin and marijuana smoking","volume":"43","author":"Yamreudeewong","year":"2009","journal-title":"Ann Pharmacother"},{"issue":"2","key":"key20170503173538_b18-cpcem-01-122","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/jcpt.12364","article-title":"Pharmacy-led medication reconciliation programmes at hospital transistions: a systematic review and meta-analysis","volume":"41","author":"Mekonnen","year":"2016","journal-title":"J Clin Pharm Ther"},{"issue":"1","key":"key20170503173538_b19-cpcem-01-122","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/jhm.2493","article-title":"Impact of pharmacist involvement in the transitional care of high risk patients through medication reconciliation, medication education, and postdischarge call-backs (IPITCH study)","volume":"11","author":"Phatak","year":"2016","journal-title":"J Hosp Med"}],"container-title":["Clinical Practice and Cases in Emergency Medicine"],"original-title":[],"language":"en","deposited":{"date-parts":[[2017,5,3]],"date-time":"2017-05-03T17:35:51Z","timestamp":1493832951000},"score":1,"resource":{"primary":{"URL":"http:\/\/escholarship.org\/uc\/item\/4z99356h"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,15]]},"references-count":19,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,3,15]]},"published-print":{"date-parts":[[2017,5]]}},"alternative-id":["10.5811\/cpcem.2016.12.33002"],"URL":"https:\/\/doi.org\/10.5811\/cpcem.2016.12.33002","relation":{},"ISSN":["2474-252X"],"issn-type":[{"value":"2474-252X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,15]]}}}